Related references
Note: Only part of the references are listed.Lifetime Medical Costs of Knee Osteoarthritis Management in the United States: Impact of Extending Indications for Total Knee Arthroplasty
Elena Losina et al.
ARTHRITIS CARE & RESEARCH (2015)
Risk Factors for Revision Within 10 Years of Total Knee Arthroplasty
Christopher J. Dy et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2014)
Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
Peter J. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cost-effectiveness analysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee pain
Hind T. Hatoum et al.
JOURNAL OF MEDICAL ECONOMICS (2014)
Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
E. Losina et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis
Francis Berenbaum et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
The effect of intra-articular hyaluronic acid treatment on gait velocity in older knee osteoarthritis patients: A randomized, controlled study
Joseph E. DeCaria et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2012)
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
Marc C. Hochberg et al.
ARTHRITIS CARE & RESEARCH (2012)
Epidemiology of Osteoarthritis
Yuqing Zhang et al.
CLINICS IN GERIATRIC MEDICINE (2010)
A Double-Blind, Randomized, Saline-Controlled Study of the Efficacy and Safety of EUFLEXXA® for Treatment of Painful Osteoarthritis of the Knee, With an Open-Label Safety Extension (The FLEXX Trial)
Roy D. Altman et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
What does the value of modern medicine say about the $50,000 per Quality-Adjusted Life-Year decision rule?
R. Scott Braithwaite et al.
MEDICAL CARE (2008)
A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee
M Kirchner et al.
OSTEOARTHRITIS AND CARTILAGE (2006)
Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee
RD Altman et al.
OSTEOARTHRITIS AND CARTILAGE (2004)
Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis.: A controlled, randomized, double-blind, parallel-design multicentre study
J Karlsson et al.
RHEUMATOLOGY (2002)
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results
GW Torrance et al.
OSTEOARTHRITIS AND CARTILAGE (2002)
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results
JP Raynauld et al.
OSTEOARTHRITIS AND CARTILAGE (2002)
Share Paper
